Ledger.Open graph →
SEC Form D · filed September 25, 2017

Alcresta Therapeutics, Inc

Offering
$35.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Warren, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Matt Lindenberger · Miami, FLExec · DirectorAdib Mattar · Miami, FLDirectorDavid Kownator · Miami, FLDirectorAri Ojalvo · Miami, FLDirectorJonathan Hong · Miami, FLExecTheresa Mohan · Miami, FLDirectorJames Topper · Seattle, WADirectorDaniel Tasse · Clinton, NJExec · DirectorMartin Paz · Newton, MAExecCharles T. Holland · NEW YORK, NYDirectorHoward Mergelkamp · Cromwell, CTDirectorFiona P. Mulhall · Dublin, IrelandExec · DirectorBrian P. Murphy · Darien, CTExecStephen Pearce · London, United KingdomDirectorGlynn Phillips · London, United KingdomDirectorEric First · Warren, NJExecJames Topper · Newton, MADirectorDaniel Tasse · Hampton, NJExec · DirectorMartin Paz · Newton, MAExecJames Gamgort · Warren, NJExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗